Pharmacologic treatment of the catastrophic epilepsies

被引:11
|
作者
Conry, JA [1 ]
机构
[1] George Washington Univ, Sch Med, Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA
关键词
pharmacotherapy; epilepsy; infantile spasms; Lennox-Gastaut syndrome; progressive myoclonic epilepsy;
D O I
10.1111/j.0013-9580.2004.05004.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Treatment of the Catastrophic epilepsies [infantile spasms (IS), Lennox-Gastaut syndrome (LGS), and progressive myoclonic epilepsy (PME)] remains a challenge to clinicians. For IS, adrenocorticotropic hormone has traditionally been the drug of choice in the United States but may be associated with serious side effects in some patients. Vigabatrin has shown promise in treating IS patients, particularly those with tuberous sclerosis. However, the drug is associated with visual field loss and is not commercially available in the United States. Newer antiepilepsy drugs (AEDs), such as zonisamide, topiramate (TPM), and lamotrigine (LTG), may be useful in patients with IS. Although LTG, TPM, and felbamate are approved in the United States for the treatment of LGS, the overall effectiveness of therapy in patients with LGS is poor. For PME, valproate is a first-line treatment. Zonisamide and levetiracetam also show promise. Supplementation with certain cofactors to correct deficiencies and increase mitochondrial function may be useful in some patients with PME, but response to such therapy is not well documented. Advances in our understanding of the etiologies, mechanisms, and genetics underlying the catastrophic epilepsies may facilitate more effective pharmacologic interventions.
引用
收藏
页码:12 / 16
页数:5
相关论文
共 50 条
  • [31] Epilepsy related factors inducing lower respiratory tract affections in children with catastrophic epilepsies
    Veendrick-Meekes, Monique J.
    Gunning, Boudewijn B.
    Steenbeek, Loek L.
    EPILEPSIA, 2006, 47 : 288 - 288
  • [32] Clinical, neuro-radiological and prognostic aspects of post-encephalitic catastrophic epilepsies
    Nieto-Barrera, M
    REVISTA DE NEUROLOGIA, 2002, 35 : S30 - S38
  • [33] RESULTS OF STEREOTAXY IN THE TREATMENT OF THE EPILEPSIES
    CIGANEK, L
    SRAMKA, M
    NADVORNIK, P
    ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1980, 50 (3-4): : P108 - P108
  • [34] TREATMENT OF PROGRESSIVE INFANTILE EPILEPSIES
    DENEGRI, M
    RAVERA, G
    VENESELLI, E
    GASLINI, 1975, 7 (02): : 145 - 153
  • [35] VALPROATE IN THE TREATMENT OF PARTIAL EPILEPSIES
    CHADWICK, D
    EPILEPSIA, 1994, 35 : S96 - S98
  • [36] Advancing pharmacologic treatment options for pharmacologic treatment options for children with epilepsy
    Auvin, Stephane
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (11) : 1475 - 1482
  • [37] Pharmacologic treatment of fibromyalgia
    Barkhuizen A.
    Current Pain and Headache Reports, 2001, 5 (4) : 351 - 358
  • [38] Insomnia Pharmacologic Treatment
    Lou, Becky X.
    Oks, Margarita
    CLINICS IN GERIATRIC MEDICINE, 2021, 37 (03) : 401 - 415
  • [39] Pharmacologic treatment of tremor
    Wasielewski, PG
    Burns, JM
    Koller, WC
    MOVEMENT DISORDERS, 1998, 13 : 90 - 100
  • [40] Pharmacologic treatment of tinnitus
    Lee, Hyun-Jin
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2022, 65 (12): : 831 - 840